The closure of the CDC's leading laboratory focused on sexually transmitted diseases (STDs) has raised significant concerns among health experts and the public. Many believe that this lab was crucial for monitoring and diagnosing complex infections such as drug-resistant Trichomonas, which commercial labs often do not handle due to economic viability. Commenters express dismay at losing such expertise and describe it as detrimental to public health efforts against infectious diseases. The lab's closure also casts doubt on the development of potential vaccines, such as a herpes vaccine being pursued by Moderna, which could have substantial health and economic implications due to its association with broader health issues like Alzheimer's disease.